Genus plc 8.7% Potential Upside Indicated by Liberum Capital

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Genus plc with EPIC/TICKER (LON:GNS) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Liberum Capital. Genus plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set their target price at 3450 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 8.7% from the opening price of 3174 GBX. Over the last 30 and 90 trading days the company share price has increased 334 points and increased 544 points respectively. The 1 year high share price is 3218 GBX while the year low stock price is currently 2122 GBX.

Genus plc has a 50 day moving average of 2,994.61 GBX and the 200 Day Moving Average price is recorded at 2,666.39. There are currently 263,178,033 shares in issue with the average daily volume traded being 76,181. Market capitalisation for LON:GNS is £2,074,477,220 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Genus plc (LON:GNS) announces interim results for 6 months ended 31 Dec 2023. Resilient revenue amidst challenges; profit lower year on year.

      Search

      Search